Popular Articles

Sleep Laboratory Finds Insomnia With Short Sleep Duration Is A Risk Factor For Diabetes
Individuals with insomnia and objective short sleep duration are at increased risk for developing diabetes, according to a research abstract presented at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies.
pharmacy online
Maryland Stem Cell Research Commission Announces 59 Projects For Funding
The Maryland Stem Cell Research Commission (Commission) has completed its evaluation of the 147 applications in response to its three official Requests for Applications (RFAs). The board of directors of the Maryland Technology Development Corporation (TEDCO) reviewed the Commission"s recommendations today and approved 59 projects totaling $18.9 million in funding through the Maryland Stem Cell Research Fund (MSCRF) under the Maryland Stem Cell Research Act of 2006.
News of the day
FDA Takes Enforcement Action Against Cheese Manufacturer
The U.S. Department of Justice, on behalf of the U.S. Food and Drug Administration, filed a complaint seeking injunctive relief against Peregrina Cheese, Inc., (Peregrina Cheese), Brooklyn, N.Y. and two of its officers: Javier Peregrina and Isabel Peregrina.
Diagnostics

PhRMA's Tally: $40 Million To Lobby On Health Care

NPR reports on one of the most powerful players in health care: the Pharmaceutical Research and Manufacturers of America, or PhRMA. In addition to spending $40 million, PhRMA alone has 29 people lobbying for it and has "hired 45 different Washington, D.C., lobbying firms to represent it in those three months of the second quarter." NPR reports: "It represents just 32 brand-name drug companies, but it has so much influence that when Congress passes a bill, PhRMA almost always gets its way." "Any firm that spends significant money lobbying Congress has to file a quarterly report. Monday was the deadline for the second quarter, providing a chance to peer into three critical months in the health care debate: April, May and June. That"s when Congress really got down to business with health care. In those three months, PhRMA spent just over $6 million, which breaks down to about $2 million a month. But the reports filed by the companies that belong to PhRMA reveal that during this same period, all but a few of them were running their own lobby shops as well." PhRMA has been advertising and its CEO has been emphasizing the group"s support for reform. NPR notes that if you want to see how PhRMA is influencing the debate, look at what issues have been removed from the table, such as drug re-importation from Canada. "This is not to pass judgment on the merits of PhRMA"s arguments, but rather to show just how much money and lobbying it uses to back them up - and the winning streak in Congress that follows" (Seabrook and Overby, 7/23). This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):